Article in Current issues in molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed.
Drug design, development and therapy · 2026
Review
4 · The record
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors.
Jiabei ChenCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China.ORCID 0000-0003-2694-0562
Chenglu LiuCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China.
Xinbo ChenCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China.ORCID 0000-0002-8758-0591
Zhen LiCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China.ORCID 0009-0000-0454-3588
Hua YangCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China.ORCID 0000-0002-6852-8210
Funding
the Department of Agriculture and Rural Affairs of Hunan Province's "Hunan Agriculture Research System" HARS-11the Joint Talent Introduction Program of Yuelushan Laboratory 2024RC2052the Postgraduate Scientific Research Innovation Projectof Hunan Province QL20230167the Research and Development of Polygonatum odoratum Superior Variety Purification, Reinforcement and Seedling Propagation Technology System xczx-2023195the Shaodong Traditional Chinese Medicine Characteristic Industrial Base Construction Agreement xczx-2023027the Yuelushan Laboratory's First Batch of Seed Industry Projects YLS-2025-ZY02030
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Elucidating the Multi-Target Anti-Pruritic Mechanism of · full record | OpenQuestion